Latest News
Video
In utero efavirenz, dolutegravir exposure linked to childhood neurologic problems
SAN FRANCISCO – Still looking for the safest antiretroviral regimen during pregnancy.
Conference Coverage
Opiate use tied to hepatitis C risk in youth
SAN FRANCISCO – A large, nationwide survey suggests the need for more hepatitis C virus testing among adolescents and young adults with opiate use...
From the Journals
Studies reveal pregnancy trends in American women with MS
From the Journals
Amitriptyline may be an alternative treatment for chronic low back pain
Latest News
Employer health insurance: Deductibles rising faster than wages
Two trends combine for an effective 212% increase in worker deductibles over the past decade.
News
Dr. Bernard Maria Recognized With Prestigious Child Neurology Honor
Bernard Maria, MD, MBA, Director of the Division of Child Neurology and Developmental Medicine at Goryeb Children’s Hospital in Morristown, NJ,...
Latest News
Neurologic disease eventually affects half of women and one-third of men
Around one-half of women and one-third of men are likely to develop either stroke, dementia, or parkinsonism during their lifetime.
From the Journals
Concurrent ‘never event’ prescribing may worsen dementia in Parkinson’s
Antidementia medication use was associated with older adults who were black and Hispanic.
Latest News
FDA Approves Galcanezumab for Migraine Prevention
ROCKVILLE, MD—The FDA has approved galcanezumab-gnlm (Emgality) for the preventive treatment of migraine in adults. Eli...
Conference Coverage
Antithrombotic strategy 1 year after stenting in AF patients leans toward oral anticoagulant alone
SAN DIEGO – A primary endpoint failed to show noninferiority of oral anticoagulants alone versus anticoagulants plus antiplatelet therapy, but a...
FDA/CDC
Emgality approved for migraine prevention in adults
The calcitonin gene–related peptide antagonist was tested in both episodic and chronic migraine.